Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients
Objective. This prospective study aimed to evaluate the value of the cardiac cycle time-corrected electromechanical activation time (EMATc) measured at admission for predicting major cardiac adverse events (MACEs) in hospitalized patients with chronic heart failure (CHF). Methods. CHF patients with...
Saved in:
Main Authors: | Jing Zhang, Wen-Xian Liu, Shu-Zheng Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2020/4532596 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
by: Zhiyong Li, et al.
Published: (2022-01-01) -
Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
by: Ericha G Franey, et al.
Published: (2020-01-01) -
Association of preoperative blood biomarkers with postoperative major adverse cardiac events and mortality in major orthopaedic surgery: a systematic review and meta-analysis
by: Lin Lu, et al.
Published: (2025-01-01) -
Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
by: Jing Ye, et al.
Published: (2019-01-01) -
The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
by: Botey Katamu Benjamin, et al.
Published: (2021-01-01)